UPSC Exam  >  UPSC Questions  >   Consider the following statements:Statement-... Start Learning for Free
Consider the following statements:
Statement-I:
Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.
Statement-II:
The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.
Which one of the following is correct in respect of the above statements?
  • a)
    Both Statement-I and Statement-II are correct and Statement-II explains Statement-I
  • b)
    Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-I
  • c)
    Statement-I is correct, but Statement-II is incorrect
  • d)
    Statement-I is incorrect, but Statement-II is correct
Correct answer is option 'B'. Can you explain this answer?
Most Upvoted Answer
Consider the following statements:Statement-I:Novo Nordisk has reques...

Statement-I correctly mentions Novo Nordisk's request to halt compounding of its medications due to safety concerns, as per the information provided in the text. Statement-II is also accurate in stating the FDA's allowance for compounding medications during shortages. However, Statement-II does not directly explain the reason behind Novo Nordisk's request, making option (b) the correct choice.
Explore Courses for UPSC exam

Top Courses for UPSC

Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer?
Question Description
Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? for UPSC 2024 is part of UPSC preparation. The Question and answers have been prepared according to the UPSC exam syllabus. Information about Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? covers all topics & solutions for UPSC 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer?.
Solutions for Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? in English & in Hindi are available as part of our courses for UPSC. Download more important topics, notes, lectures and mock test series for UPSC Exam by signing up for free.
Here you can find the meaning of Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer?, a detailed solution for Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? has been provided alongside types of Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice Consider the following statements:Statement-I:Novo Nordisk has requested US authorities to halt the compounding of its weight-loss medication, Wegovy, and the diabetes drug, Ozempic, due to safety concerns.Statement-II:The US Food and Drug Administration (FDA) allows licensed pharmacists or physicians to compound medications during shortages of commercial formulations, including the active ingredient semaglutide found in Wegovy and Ozempic.Which one of the following is correct in respect of the above statements?a) Both Statement-I and Statement-II are correct and Statement-II explains Statement-Ib) Both Statement-I and Statement-II are correct, but Statement-II does not explain Statement-Ic) Statement-I is correct, but Statement-II is incorrectd) Statement-I is incorrect, but Statement-II is correctCorrect answer is option 'B'. Can you explain this answer? tests, examples and also practice UPSC tests.
Explore Courses for UPSC exam

Top Courses for UPSC

Explore Courses
Signup for Free!
Signup to see your scores go up within 7 days! Learn & Practice with 1000+ FREE Notes, Videos & Tests.
10M+ students study on EduRev